Pharmaceutical Price Schemes in Europe: Time for a ‘Continental’ One? Livio GarattiniAlessandro CurtoNick Freemantle Commentary 28 January 2016 Pages: 423 - 426
Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right? Beth WoodsRita FariaSusan Griffin Current Opinion 29 December 2015 Pages: 427 - 433
Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment Aris AngelisPanos Kanavos Practical Application Open access 06 January 2016 Pages: 435 - 446
Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches Dyfrig HughesJoanna CharlesSeow Tien Yeo Review Article 11 January 2016 Pages: 447 - 461
Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Abdullah PandorDaniel PollardMatt Stevenson Review Article 21 December 2015 Pages: 463 - 477
Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature Simon FreyCarl R. BlankartTom Stargardt Systematic Review 06 January 2016 Pages: 479 - 498
Complex Valuation: Applying Ideas from the Complex Intervention Framework to Valuation of a New Measure for End-of-Life Care Joanna CoastElisabeth HuynhTerry Flynn Original Research Article 29 December 2015 Pages: 499 - 508
Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study Kathryn CoyleDoug CoyleMike Innes Original Research Article Open access 06 January 2016 Pages: 509 - 520
EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria Emma HaweDoreen McBrideDonald E. Stull Original Research Article Open access 20 January 2016 Pages: 521 - 527
